What Pharma Investors Need to Know About Pfizer's Latest Disaster [The Motley Fool]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: The Motley Fool
What Pharma Investors Need to Know About Pfizer's Latest Disaster Pfizer ( NYSE:PFE AbbVie NYSE:ABBV Gilead Sciences NASDAQ:GILD Xeljanz isn't the only drug of its class associated with lethal blood clots, and there's a chance the Food and Drug Administration could try to hinder AbbVie and Gilead Sciences from launching another one. Here's how Pfizer's latest problem could shake out for everyone involved. Image source: Getty Images. What happened Two years after Xeljanz earned approval to treat rheumatoid arthritis (RA), Pfizer began a safety study with ,00 RA patients to look for safety differences between older injections like Humira Data monitors also reported a higher rate of overall mortality among patients given 0 mg twice daily, compared to patients given mg twice daily or Humira. In response, Pfizer will transition all the patients in the 0 mg group to the mg cohort and hope for the best. Reasons to relax It's important to note that all the RA patients in Pfizer's post-marke
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Inhalation CDMO Global Research Report 2024-2033: Integration of AI and ML Enhances Capabilities, Biopharmaceutical Inhalation Therapies Rapidly Expand, Patient-Centric Solutions Take Center Stage [Yahoo! Finance]Yahoo! Finance
- Obsessive-Compulsive Disorder (OCD) Global Clinical Trials Review 2024: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status [Yahoo! Finance]Yahoo! Finance
- UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology [Yahoo! Finance]Yahoo! Finance
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology [Yahoo! Finance]Yahoo! Finance
- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology [Reuters]Reuters
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form PX14A6G
- PFE's page on the SEC website